As of January 23, 2025, CervoMed (CRVO) has a market cap of $17.993 million USD. According to our data, CervoMed is ranked No.8649 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $17.99 M |
-6.84%
|
Dec 31, 2024 | $19.31 M |
-69.33%
|
Dec 29, 2023 | $62.98 M |
0.53%
|
Dec 30, 2022 | $62.65 M |
-67.35%
|
Dec 31, 2021 | $0.19 B |
-61.25%
|
Dec 31, 2020 | $0.50 B |
73.91%
|
Dec 31, 2019 | $0.28 B |
-76.88%
|
Dec 31, 2018 | $1.23 B |
-88.76%
|
Dec 29, 2017 | $10.96 B |
-47.79%
|
Dec 30, 2016 | $20.99 B |
-77.40%
|
Dec 31, 2015 | $92.85 B |
-69.70%
|
Dec 31, 2014 | $306.42 B |
10.00%
|
Dec 31, 2013 | $278.56 B |
-84.21%
|
Dec 31, 2012 | $1.764 T |
-62.00%
|
Dec 30, 2011 | $4.643 T |
-21.88%
|
Dec 31, 2010 | $5.943 T |
-71.56%
|
Dec 31, 2009 | $20.892 T |
41.51%
|
Dec 31, 2008 | $14.764 T |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Market Cap | = | CRVO Stock Price | * | CRVO Shares Outstanding |
= | $2.18 | * | 8.25 M | |
= | $17.99 M |